Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment

Nonna Shakhnazaryan1, Liam Gima-Lange1, Arpita Desai2

  • 1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

Urologic Oncology
|July 2, 2024
PubMed
Abstract

Insights

Patient websites for metastatic renal cell carcinoma (mRCC) treatments often lack accurate and complete information. Improving the quality and readability of this online content is crucial for informed patient decision-making.

Area of Science:

  • Oncology
  • Medical Informatics
  • Health Communication

Background:

  • Patients with metastatic renal cell carcinoma (mRCC) require accessible and reliable treatment information.
  • Online resources are a primary source for patient-led health research.
  • The quality of online patient educational materials for mRCC is largely unevaluated.

Purpose of the Study:

  • To evaluate the accuracy, readability, and quality of patient-facing websites detailing mRCC treatments.

Main Methods:

  • A systematic search identified 39 eligible English-language websites.
  • Accuracy was assessed for completeness (NCI PDQ checklist) and correctness (guideline adherence).
  • Readability was measured using Fry and SMOG formulae; quality was assessed via QUEST and DISCERN instruments.

Main Results:

  • Only 5% of websites met completeness criteria (≥60% facts).
  • 31% contained incorrect statements, including non-standard therapies.
  • Readability averaged 11th-12th grade levels, with variable quality scores (mean QUEST: 19, mean DISCERN: 56).

Conclusions:

  • Online information on mRCC treatments is frequently incomplete and inaccurate.
  • Variable website quality and high reading levels pose challenges for patient comprehension.
  • Enhancing the accuracy, readability, and quality of these resources is essential to prevent patient harm and support informed decisions.